Alkermes (ALKS) PT Lowered to $55.00

Alkermes (NASDAQ:ALKS) had its target price trimmed by Cowen to $55.00 in a research note published on Monday morning. The brokerage currently has an outperform rating on the stock.

A number of other equities analysts have also weighed in on the company. Credit Suisse Group reaffirmed a buy rating and issued a $53.00 price objective on shares of Alkermes in a research note on Monday. They noted that the move was a valuation call. Cantor Fitzgerald dropped their price objective on Alkermes to $45.00 and set a neutral rating for the company in a research note on Monday. BidaskClub raised Alkermes from a hold rating to a buy rating in a research note on Wednesday, March 28th. Morgan Stanley reaffirmed an equal weight rating and issued a $67.00 price objective (up previously from $60.00) on shares of Alkermes in a research note on Friday, February 23rd. Finally, Jefferies Group lowered Alkermes from a buy rating to a hold rating and increased their price target for the company from $63.19 to $66.00 in a research note on Thursday, February 22nd. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company’s stock. Alkermes has a consensus rating of Hold and a consensus target price of $60.67.

How to Become a New Pot Stock Millionaire

NASDAQ ALKS opened at $42.69 on Monday. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.78 and a quick ratio of 2.46. Alkermes has a twelve month low of $41.15 and a twelve month high of $71.22.

Alkermes (NASDAQ:ALKS) last released its quarterly earnings data on Wednesday, February 14th. The company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.32. The firm had revenue of $275.37 million during the quarter, compared to analyst estimates of $251.23 million. Alkermes had a negative return on equity of 4.32% and a negative net margin of 17.48%. The business’s quarterly revenue was up 29.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.02 earnings per share. equities analysts anticipate that Alkermes will post -0.8 EPS for the current fiscal year.

In other Alkermes news, SVP Mark Stejbach sold 10,880 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $70.50, for a total transaction of $767,040.00. Following the sale, the senior vice president now directly owns 54,893 shares in the company, valued at $3,869,956.50. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Shane Cooke sold 6,207 shares of the company’s stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $60.22, for a total value of $373,785.54. Following the sale, the insider now owns 80,915 shares in the company, valued at $4,872,701.30. The disclosure for this sale can be found here. Over the last three months, insiders have sold 97,880 shares of company stock valued at $6,009,036. 5.34% of the stock is owned by corporate insiders.

Hedge funds have recently modified their holdings of the business. First Trust Advisors LP raised its position in Alkermes by 18.6% during the fourth quarter. First Trust Advisors LP now owns 800,752 shares of the company’s stock valued at $43,825,000 after purchasing an additional 125,309 shares during the period. Bailard Inc. purchased a new stake in Alkermes during the fourth quarter valued at approximately $274,000. Schwab Charles Investment Management Inc. raised its position in Alkermes by 5.0% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 493,515 shares of the company’s stock valued at $27,011,000 after purchasing an additional 23,712 shares during the period. Janus Henderson Group PLC raised its position in Alkermes by 13.7% during the third quarter. Janus Henderson Group PLC now owns 2,650,006 shares of the company’s stock valued at $134,726,000 after purchasing an additional 319,014 shares during the period. Finally, AMP Capital Investors Ltd raised its position in Alkermes by 11.0% during the third quarter. AMP Capital Investors Ltd now owns 53,745 shares of the company’s stock valued at $2,732,000 after purchasing an additional 5,306 shares during the period.

COPYRIGHT VIOLATION WARNING: This piece of content was published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3335055/alkermes-alks-pt-lowered-to-55-00.html.

Alkermes Company Profile

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS).

Analyst Recommendations for Alkermes (NASDAQ:ALKS)

Receive News & Ratings for Alkermes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alkermes and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

ArQule, Inc.  Expected to Announce Earnings of -$0.06 Per Share
ArQule, Inc. Expected to Announce Earnings of -$0.06 Per Share
Anglo American  Downgraded by Zacks Investment Research to Hold
Anglo American Downgraded by Zacks Investment Research to Hold
BMO Capital Markets Analysts Give Trevali Mining  a C$2.00 Price Target
BMO Capital Markets Analysts Give Trevali Mining a C$2.00 Price Target
Atlas Copco  Downgraded by Zacks Investment Research to Hold
Atlas Copco Downgraded by Zacks Investment Research to Hold
Algonquin Power & Utilities  Given a C$15.50 Price Target at BMO Capital Markets
Algonquin Power & Utilities Given a C$15.50 Price Target at BMO Capital Markets
BJ’s Restaurants  Stock Rating Upgraded by BidaskClub
BJ’s Restaurants Stock Rating Upgraded by BidaskClub


Leave a Reply

© 2006-2018 Ticker Report. Google+.